ALEKSANDER DEDO: Open Payments
NPI 1396468500 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,992 in 30 payments from 11 companies in 2025. Trend: 2023 $985 · 2024 $1,240 · 2025 $1,992
Food & beverage: $1,906Education: $85
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $330 |
| Janssen Biotech, Inc. | 11 | $295 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $288 |
| Galderma Laboratories, L.P. | 2 | $263 |
| ABBVIE INC. | 3 | $197 |
| Lilly USA, LLC | 2 | $174 |
| GENZYME CORPORATION | 3 | $171 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Cipher Pharmaceuticals US LLC | 1 | $108 |
| UCB, Inc. | 1 | $24 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, EBGLYSS, Leqselvi, SKYRIZI, ILUMYA, Natroba.
Industry payments across PA — which companies pay providers there.
